Resveratrol Supplement: Benefits, Dosage and What the Science Actually Shows

What is resveratrol?

Resveratrol is a polyphenol produced by plants in response to stress, injury, and pathogen attack. It belongs to a class of compounds called stilbenes, and its best-known natural sources are the skins of red grapes, blueberries, mulberries, and the root of Japanese knotweed. Red wine contains small amounts from grape skin contact during fermentation, though the actual concentration per glass is well below what clinical research uses.

The compound was first isolated in 1940 from white hellebore, but interest accelerated sharply in the 1990s when researchers identified it as a candidate explanation for the so-called French paradox: the observation that populations with relatively high saturated fat intake but also high red wine consumption showed lower cardiovascular event rates than expected. Resveratrol became a focal point of longevity research following a 2003 paper demonstrating that it extended lifespan in yeast by activating a class of proteins called sirtuins.

Trans-resveratrol versus cis-resveratrol: why the distinction matters

Resveratrol exists in two geometric forms: trans-resveratrol and cis-resveratrol. These share the same molecular formula but have different three-dimensional structures, and that structural difference has real biological consequences.

Trans-resveratrol is the biologically active form. It is the isomer that binds to sirtuin enzymes, shows activity in cardiovascular models, and is used in virtually all published human clinical trials. Cis-resveratrol, by contrast, shows substantially weaker activity in cell-based assays and is not considered the therapeutically relevant form.

The problem is that resveratrol converts between these two forms when exposed to light. A supplement stored in clear packaging or sitting on a brightly lit shelf can shift toward the less active cis configuration over time. Quality supplements specify the trans-resveratrol percentage on the label and use amber or opaque packaging. If a product does not specify the isomer, or lists only total resveratrol, treat that as a flag.

What the research actually shows

Resveratrol has accumulated a large body of preclinical evidence, a smaller but growing set of human studies, and some genuinely promising mechanistic data. Here is what the science currently supports across the main outcome areas.

Cardiovascular health. This is where resveratrol has the most consistent human evidence. Multiple trials in people with metabolic risk factors have found reductions in systolic blood pressure, improvements in endothelial function (the ability of blood vessels to dilate appropriately), and reductions in markers of oxidative stress. A meta-analysis of randomised controlled trials published in the American Journal of Clinical Nutrition found significant reductions in systolic pressure at doses of 150 mg or more per day. Effects on LDL cholesterol are more mixed, with some trials showing modest reductions and others showing no significant change.

Sirtuin activation and longevity pathways. Resveratrol is one of the most studied activators of SIRT1, the human equivalent of the yeast Sir2 protein whose activation extends lifespan in model organisms. SIRT1 regulates a broad network of metabolic genes, promotes mitochondrial biogenesis, and plays a role in the cellular stress response. Whether these mechanistic effects translate into meaningful longevity benefits in humans remains an open question, but the pathway is real and well-characterised. Resveratrol activates SIRT1 both directly and indirectly through upstream effects on AMPK, an energy-sensing enzyme that is also activated by caloric restriction and exercise.

Anti-inflammatory effects. Resveratrol inhibits NF-kB, one of the master regulators of inflammatory signalling, and reduces circulating levels of IL-6 and TNF-alpha in clinical studies. These effects appear most pronounced in people with baseline inflammatory conditions. A 2017 systematic review found that resveratrol supplementation significantly reduced CRP (C-reactive protein) in people with elevated baseline levels, while effects were smaller in healthy populations with already-low inflammation markers.

Metabolic and insulin sensitivity. Several trials in people with type 2 diabetes or metabolic syndrome have found improvements in insulin sensitivity and reductions in fasting glucose following resveratrol supplementation. The mechanisms likely involve SIRT1 and AMPK activation improving mitochondrial function in muscle and liver tissue. Effects in healthy, metabolically normal individuals are less consistently demonstrated.

Dosage: what the clinical evidence uses

Human trials have used a wide range of doses, from 75 mg to 5,000 mg per day. The majority of positive cardiovascular and metabolic findings cluster in the 150 mg to 500 mg per day range. Very high doses (above 1,000 mg daily) have not shown proportionally greater benefit in most outcomes and can cause gastrointestinal discomfort in some individuals.

For most people seeking the cardiovascular and sirtuin-related benefits documented in research, 150 to 500 mg of trans-resveratrol per day represents a reasonable target. Starting at the lower end and assessing tolerability is a sensible approach. Daily consistency matters more than occasional high doses, given that resveratrol is metabolised quickly and does not accumulate significantly in tissue.

The bioavailability problem and how better formulations address it

Resveratrol has a fundamental pharmacokinetic limitation: it is absorbed reasonably well in the gut but is then rapidly conjugated (chemically modified) by the intestinal wall and liver before it reaches systemic circulation. Peak plasma levels after a standard oral dose are reached within 30 to 60 minutes but fall off quickly. The compound is also poorly soluble in water, which limits absorption from the gut lumen.

Several formulation approaches have been developed to address this. Micronised resveratrol, which reduces particle size to dramatically increase surface area, shows significantly improved bioavailability compared with standard powder in direct comparison studies. One pharmacokinetic trial found that a micronised preparation produced plasma concentrations roughly 3.6 times higher than the equivalent standard dose. Liposomal encapsulation, which wraps the molecule in a fat-based carrier, is another approach with supporting data, though the evidence base is smaller than for micronisation.

What this means practically: the dose on the label is not a direct predictor of how much reaches your tissues. A 250 mg dose of micronised trans-resveratrol is likely to deliver meaningfully more bioavailable compound than 500 mg of standard crystalline powder. When comparing products, look for explicit bioavailability claims backed by data, not just higher headline doses.

Resveratrol and NMN: how they work together

Resveratrol and NMN (nicotinamide mononucleotide) are often discussed together in the context of sirtuin biology, and the synergy between them has a clear mechanistic basis.

Sirtuins are NAD-dependent enzymes. They require NAD+ as a co-substrate to function. As we age, cellular NAD+ levels decline significantly, and this decline is thought to be one reason that sirtuin activity diminishes with age. NMN works by raising NAD+ levels, restoring the fuel that sirtuins need to operate. Resveratrol works as a sirtuin activator, making the enzymes more responsive to NAD+. Together, they address both sides of the equation: substrate availability and enzyme sensitivity.

This is not just theoretical. Cell studies combining NAD+ precursors with resveratrol show additive effects on sirtuin-regulated gene expression that neither compound achieves alone at the same doses. Human trial data on the combination specifically is limited, but the mechanistic case for co-administration is one of the stronger arguments in longevity supplement research. Our NMN and resveratrol stack guide covers the practical details of combining these two supplements, including timing and relative dosing.

What to look for when buying a resveratrol supplement

The supplement market for resveratrol is uneven in quality. These are the specific factors that distinguish a well-made product from a mediocre one:

• Trans-resveratrol specification. The label should state trans-resveratrol percentage or content explicitly. Products listing only total polyphenols or total resveratrol without isomer specification are using imprecise language that obscures actual potency.
• Source and purity. Japanese knotweed (Polygonum cuspidatum) root extract is the most common commercial source and produces reliably high trans-resveratrol concentrations when properly processed. The purity of the extract should be stated, ideally with a percentage (for example, 98% trans-resveratrol).
• Dose per serving. For cardiovascular and metabolic benefits, a minimum of 150 mg trans-resveratrol per serving is supported by the clinical literature. Products delivering less than 100 mg per capsule at normal serving sizes are unlikely to reach the threshold doses used in positive trials.
• Formulation for bioavailability. Look for micronised resveratrol or liposomal delivery if bioavailability enhancement is claimed. If a standard powder is used, higher doses may be needed to compensate for lower absorption.
• Third-party testing. Independent laboratory verification of trans-resveratrol content is the only way to confirm that what is on the label is in the capsule. Look for a certificate of analysis from a named, accredited laboratory, with a batch number that matches the product you are buying.
• Light-protective packaging. Amber glass or opaque containers protect the trans-resveratrol from isomerisation. Clear bottles are a practical disadvantage.
• GMP manufacturing. Good Manufacturing Practice certification indicates that the facility producing the supplement operates under validated quality systems, reducing the risk of contamination or mislabelling.

When to take resveratrol

Resveratrol is fat-soluble, meaning absorption improves significantly when taken with a meal containing dietary fat. Studies comparing fasted versus fed administration consistently show higher plasma levels in the fed state. A practical approach is to take resveratrol with your largest meal of the day, or with a meal that contains a moderate amount of fat.

Timing relative to NMN is flexible. Many people take both supplements together with their first or largest meal. There is no evidence that the compounds interfere with each other's absorption, and the mechanistic case for co-administration is not time-dependent in the short term. See the NMN stack guide for a broader discussion of how resveratrol fits into a longevity supplement protocol.

One note on consistency: resveratrol does not accumulate to a stable tissue reservoir across days in the way that fat-soluble vitamins do. Daily dosing produces more consistent exposure than intermittent large doses. If you miss a day, simply continue the next day rather than doubling the dose.

Who is resveratrol most relevant for?

The evidence base is strongest for people with existing cardiovascular risk factors or metabolic conditions. If you have elevated blood pressure, insulin resistance, or elevated inflammatory markers, there is reasonable clinical support for resveratrol as a complementary intervention alongside dietary and lifestyle measures.

For healthy younger individuals, the data on hard clinical endpoints is limited. The mechanistic and preclinical case for longevity-related benefits is genuinely interesting, and the safety profile at normal doses is good, but the honest position is that long-term human outcome data is still being generated. People using resveratrol as part of a broader sirtuin-supporting stack, particularly alongside NMN, are acting on a coherent mechanistic rationale rather than proven clinical outcomes at this point.

Related reading

• NMN and resveratrol stack: protocol and evidence
• NMN and resveratrol: how the two compounds interact
• Best resveratrol supplement: what to look for and what to avoid
• NMN stack guide: building a longevity supplement protocol
• Supplements for longevity: what the evidence supports in 2026